Ryuichi Morishita

32.8k total citations · 4 hit papers
586 papers, 25.4k citations indexed

About

Ryuichi Morishita is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ryuichi Morishita has authored 586 papers receiving a total of 25.4k indexed citations (citations by other indexed papers that have themselves been cited), including 282 papers in Molecular Biology, 136 papers in Surgery and 112 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ryuichi Morishita's work include RNA Interference and Gene Delivery (86 papers), Liver physiology and pathology (68 papers) and Virus-based gene therapy research (65 papers). Ryuichi Morishita is often cited by papers focused on RNA Interference and Gene Delivery (86 papers), Liver physiology and pathology (68 papers) and Virus-based gene therapy research (65 papers). Ryuichi Morishita collaborates with scholars based in Japan, United States and France. Ryuichi Morishita's co-authors include Toshio Ogihara, Yasufumi Kaneda, Hironori Nakagami, Motokuni Aoki, Yoshiaki Taniyama, Jitsuo Higaki, Naruya Tomita, Hiromi Rakugi, Naoyuki Sato and Kunio Matsumoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Ryuichi Morishita

577 papers receiving 24.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

1995 618 citations Ryuichi Morishita, Masatoshi Nakajima et al. Proceedings of the National Academy of Sciences profile →
The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

1995 576 citations Masatoshi Nakajima, Ryuichi Morishita et al. Proceedings of the National Academy of Sciences profile →
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

1997 521 citations Ryuichi Morishita, Motokuni Aoki et al. profile →
Hepatocyte growth factor gene therapy of liver cirrhosis in rats

1999 505 citations Yasufumi Kaneda, Ryuichi Morishita et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryuichi Morishita Japan	81	11.1k	5.7k	4.1k	3.1k	3.0k	586	25.4k
Yasufumi Kaneda Japan	79	11.8k 1.1×	4.0k 0.7×	2.4k 0.6×	2.7k 0.9×	3.4k 1.1×	470	24.5k
Toshio Ogihara Japan	89	10.2k 0.9×	6.3k 1.1×	9.7k 2.3×	4.8k 1.5×	2.4k 0.8×	893	31.9k
Masatsugu Hori Japan	91	10.7k 1.0×	5.4k 0.9×	11.3k 2.7×	3.0k 0.9×	2.7k 0.9×	537	33.2k
Guillermo García‐Cardeña United States	57	8.2k 0.7×	2.9k 0.5×	3.0k 0.7×	4.0k 1.3×	3.2k 1.0×	91	18.6k
Holger K. Eltzschig United States	88	7.9k 0.7×	4.2k 0.7×	2.9k 0.7×	2.5k 0.8×	4.4k 1.5×	290	27.3k
Gou Young Koh South Korea	86	16.6k 1.5×	4.2k 0.7×	3.9k 0.9×	4.7k 1.5×	3.2k 1.1×	274	29.2k
Allan Flyvbjerg Denmark	77	6.3k 0.6×	3.3k 0.6×	3.4k 0.8×	4.6k 1.5×	1.7k 0.6×	518	23.7k
Giovanni Camussi Italy	89	19.8k 1.8×	5.4k 0.9×	1.9k 0.5×	1.9k 0.6×	5.3k 1.7×	572	33.7k
M.A. Karsdal Denmark	78	7.8k 0.7×	3.8k 0.7×	932 0.2×	1.8k 0.6×	1.9k 0.6×	860	25.4k
Josef Pfeilschifter Germany	79	11.8k 1.1×	1.9k 0.3×	1.7k 0.4×	4.6k 1.5×	4.8k 1.6×	544	24.4k

Countries citing papers authored by Ryuichi Morishita

Since Specialization

Citations

This map shows the geographic impact of Ryuichi Morishita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichi Morishita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichi Morishita more than expected).

Fields of papers citing papers by Ryuichi Morishita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuichi Morishita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichi Morishita. The network helps show where Ryuichi Morishita may publish in the future.

Co-authorship network of co-authors of Ryuichi Morishita

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichi Morishita. A scholar is included among the top collaborators of Ryuichi Morishita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichi Morishita. Ryuichi Morishita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miyake, Tetsuo, et al.. (2022). Genetic deletion of osteoprotegerin attenuates asthma development through suppression of inflammatory response in mice. Cellular Immunology. 378. 104559–104559. 2 indexed citations

Morinaga, Jun, Hironori Nakagami, Hiroki Hayashi, et al.. (2021). Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia. Cell Reports Medicine. 2(11). 100446–100446. 29 indexed citations

Yoshida, Shota, Hironori Nakagami, Hiroki Hayashi, et al.. (2020). The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice. Nature Communications. 11(1). 2482–2482. 106 indexed citations

Shih, Chun‐Ming, Feng‐Yen Lin, Yi‐Wen Lin, et al.. (2018). Dysfunctional high density lipoprotein failed to rescue the function of oxidized low density lipoprotein-treated endothelial progenitor cells: a novel index for the prediction of HDL functionality. Translational research. 205. 17–32. 15 indexed citations

Tsukada, Yusuke, Hiroyuki Tsujimoto, Takayuki Sugimoto, et al.. (2013). Development of Oral Formulation Technology for Nucleic Acid Drug by Using PLGA Nanoparticles as DDS Carriers. Journal of the Society of Powder Technology Japan. 50(7). 513–518. 1 indexed citations

Saito, Yukihiro, Hironori Nakagami, Nobuyoshi Azuma, et al.. (2011). Critical Roles of Cold Shock Domain Protein A as an Endogenous Angiogenesis Inhibitor in Skeletal Muscle. Antioxidants and Redox Signaling. 15(8). 2109–2120. 10 indexed citations

Nagata, K, Mariko Seishima, Ryuichi Morishita, et al.. (2011). Possible role of a multi-domain adaptor protein, ArgBP2, in the tight junction maintenance of epithelial cells. Journal of Investigative Dermatology. 131. 32.

Takeda, Shuko, Naoyuki Sato, Kozue Uchio‐Yamada, et al.. (2010). Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes. Proceedings of the National Academy of Sciences. 107(15). 7036–7041. 407 indexed citations

Koriyama, Hiroshi, Hironori Nakagami, Tomohiro Katsuya, et al.. (2010). Identification of Evidence Suggestive of an Association with Peripheral Arterial Disease at the OSBPL10 Locus by Genome-Wide Investigation in the Japanese Population. Journal of Atherosclerosis and Thrombosis. 17(10). 1054–1062. 25 indexed citations

10.

Takeda, Shuko, Naoyuki Sato, Kazue Niisato, et al.. (2009). Validation of Aβ1–40 administration into mouse cerebroventricles as an animal model for Alzheimer disease. Brain Research. 1280. 137–147. 49 indexed citations

11.

Nagao, Kaori, Yoshiaki Taniyama, Nobutaka Koibuchi, & Ryuichi Morishita. (2007). Constitutive over-expression of VEGF results in reduced expression of Hand-1 during cardiac development in Xenopus. Biochemical and Biophysical Research Communications. 359(3). 431–437. 1 indexed citations

12.

Nakagami, Hironori, Yasushi Takeya, Shinichiro Hayashi, et al.. (2006). Model of Vasculogenesis from Embryonic Stem Cells for Vascular Research and Regenerative Medicine. Hypertension. 48(1). 112–119. 27 indexed citations

13.

Koibuchi, Nobutaka, Yoshiaki Taniyama, Kaori Nagao, et al.. (2006). The effect of VEGF on blood vessels and blood cells during Xenopus development. Biochemical and Biophysical Research Communications. 344(1). 339–345. 13 indexed citations

14.

Hashiya, Naotaka, et al.. (2004). 転写因子による治療的血管形成;末梢動脈疾患に対するEts-1. Circulation. 68. 501. 1 indexed citations

15.

Morishita, Ryuichi, et al.. (2002). Impairment of collateral formation in Lp(a) transgenic mice : Therapeutic angiogenesis induced by human hepatocyte growth factor (HGF) gene. Japanese Circulation Journal-english Edition. 66. 704. 1 indexed citations

16.

Hashiya, Naotaka, Motokuni Aoki, Kazuya Hiraoka, et al.. (2001). Therapeutic angiogenesis induced by HGF gene in rat diabetic hind limb ischemia model: Molecular mechanisms of delayed angiogenesis in diabetes.. Japanese Circulation Journal-english Edition. 65. 181. 2 indexed citations

17.

Sugimoto, Tohru, Yoshihiro Horii, Katsuhito Takahashi, et al.. (2000). Neuroblastoma Cell Lines Showing Smooth Muscle Cell Phenotypes. Diagnostic Molecular Pathology. 9(4). 221–228. 11 indexed citations

18.

Hayashi, Katsuhiko, S. Nakamura, Ryuichi Morishita, et al.. (2000). In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model. Gene Therapy. 7(19). 1664–1671. 69 indexed citations

19.

Nakamura, Shigefumi, Ryuichi Morishita, Atsushi Moriguchi, et al.. (1998). IS028 GENE THERAPY OF RESTENOSIS BY IN VIVO GENE TRANSFER OF HUMAN HEPATOCYTE GROWTH FACTOR (HGF) THROUGH THE ACCELATION OF RE-ENDOTHELIALIZATION. Japanese Circulation Journal-english Edition. 62. 21.

20.

Morishita, Ryuichi, et al.. (1993). Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy.. PubMed. 106. 54–61. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact